Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Doximity Inc Cl A (NY: DOCS )

24.16 -0.16 (-0.68%)
Streaming Delayed Price Updated: 3:42 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Doximity Inc Cl A

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
6 Analysts Assess Doximity: What You Need To Know
Via Benzinga
For those who appreciate growth without the sticker shock, NYSE:DOCS is worth considering.
DOXIMITY INC-CLASS A (NYSE:DOCS) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
NYSE:DOCS—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via Chartmill
6 Analysts Assess Doximity: What You Need To Know
Via Benzinga
NYSE:DOCS, a growth stock which is not overvalued.
Investors should take note ofDOXIMITY INC-CLASS A (NYSE:DOCS), a growth stock that remains attractively priced. 
Via Chartmill
What 6 Analyst Ratings Have To Say About Doximity
Via Benzinga
NYSE:DOCS—A High-Growth Stock Gearing Up for Its Next Upward Move.
Why DOXIMITY INC-CLASS A (NYSE:DOCS) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
NYSE:DOCS stands out as a growth opportunity that won't break the bank.
Investors seeking growth at a reasonable cost should explore NYSE:DOCS. 
Via Chartmill
Forecasting The Future: 5 Analyst Projections For Doximity
Via Benzinga
Is NYSE:DOCS on the Verge of a Major Breakout as a Strong Growth Stock?
DOXIMITY INC-CLASS A (NYSE:DOCS)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
Via Chartmill
HIMS Stock Breaks Out On Powerful Turnaround Quarter
"In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability.": CEO Andrew Dudum 
Via Investor's Business Daily
2 Beaten-Down Stocks to Buy and Hold for 10 Years
One is a longtime healthcare leader, the other a newcomer; both have bright futures despite recent obstacles. 
Via The Motley Fool
1 Cash-Gushing Stock Down 70% to Buy and Hold Forever
This healthcare upstart, with a free-cash-flow margin of 27% even after removing stock-based compensation, deserves a long look from investors. 
Via The Motley Fool
What's Going With Medical Professionals-Networking Service Doximity Stock Today?
Doximity exceeds Q3 2024 expectations with $135.3 million revenue, up 17% YoY. CEO Jeff Tangney highlights double-digit growth, beating adjusted EPS and raising FY2024 outlook. 
Via Benzinga
Recap: Doximity Q3 Earnings
Via Benzinga
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
In the world of growth stocks, NYSE:DOCS shines as a value proposition.
Investors seeking growth at a reasonable cost should explore DOXIMITY INC-CLASS A (NYSE:DOCS). 
Via Chartmill
The Top Healthcare Stocks to Buy With $100
These stocks haven't been popular with investors lately. 
Via The Motley Fool
Despite its growth, NYSE:DOCS remains within the realm of affordability.
For those who appreciate growth without the sticker shock, NYSE:DOCS is worth considering. 
Via Chartmill
For those who appreciate growth without the sticker shock, NYSE:DOCS is worth considering.
Don't overlook DOXIMITY INC-CLASS A (NYSE:DOCS)—a stock with solid growth prospects and a reasonable valuation. 
Via Chartmill
3 Stocks to Capitalize on the Telehealth Explosion
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic. 
Via InvestorPlace
7 Stocks that Multiple AI Bots Predict Will Soar in the Near Future
AI chatbots including ChatGPT and Bard believe these stocks are headed higher in the future, perhaps the near future. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Investors should take note of NYSE:DOCS, a growth stock that remains attractively priced.
DOXIMITY INC-CLASS A (NYSE:DOCS), a growth stock which is not overvalued. 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Future in Fitness: 3 Stocks Innovating in Digital Health
Benefitting from the tech transformations spurred by the pandemic, these three digital health stocks bring healthcare to the home. 
Via InvestorPlace
Hidden Gems: 3 Small-Cap Tech Stocks With Huge Potential
These top small-cap tech stocks are the ones to buy in for long-term returns as profits are evident from innovations. 
Via InvestorPlace
2 Magnificent Stocks That Could Go Parabolic
Down 41% and 53% from their 52-week highs, these two market-leading stocks are primed for a rebound. 
Via The Motley Fool
5 Telehealth Stocks That Have Nothing But Upside
Dive into the dynamic world of top telehealth stocks. Discover our expert analysis on the gems shaping the future of digital healthcare. 
Via InvestorPlace
NYSE:DOCS—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Why DOXIMITY INC-CLASS A (NYSE:DOCS) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
Top 5 Health Care Stocks That May Collapse In November
As of Nov. 17, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.